Woodline Partners’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17M Hold
203,585
0.06% 373
2025
Q4
$15.8M Sell
203,585
-44,415
-18% -$3M 0.06% 358
2025
Q3
$14M Sell
248,000
-250,111
-50% -$11.3M 0.07% 354
2025
Q2
$21.7M Sell
498,111
-27,134
-5% -$934K 0.11% 264
2025
Q1
$14.4M Sell
525,245
-12,183
-2% -$444K 0.09% 297
2024
Q4
$21.6M Buy
537,428
+12,334
+2% +$557K 0.15% 199
2024
Q3
$24.9M Buy
525,094
+7,297
+1% +$322K 0.21% 156
2024
Q2
$15.5M Buy
517,797
+16,867
+3% +$584K 0.15% 199
2024
Q1
$20.1M Buy
500,930
+400,179
+397% +$14.3M 0.19% 169
2023
Q4
$2.57M Sell
100,751
-2,438
-2% -$43.6K 0.03% 366
2023
Q3
$1.43M Sell
103,189
-5,592
-5% -$112K 0.02% 419
2023
Q2
$2.5M Buy
108,781
+8,771
+9% +$251K 0.03% 402
2023
Q1
$2.96M Buy
100,010
+10
+0% +$323 0.04% 373
2022
Q4
$2.5M Hold
100,000
0.03% 449
2022
Q3
$2.18M Hold
100,000
0.03% 446
2022
Q2
$1.97M Buy
+100,000
New +$2.34M 0.03% 430
2021
Q4
Sell
-129,331
Closed -$7.6M 750
2021
Q3
$7.6M Buy
129,331
+91,572
+243% +$5.31M 0.13% 198
2021
Q2
$1.83M Buy
+37,759
New +$1.64M 0.03% 374
2021
Q1
Sell
-169,687
Closed -$10.5M 451
2020
Q4
$10.5M Buy
169,687
+3,470
+2% +$169K 0.28% 112
2020
Q3
$5.37M Buy
+166,217
New +$5.07M 0.18% 124

Other funds holding KYMR